After several rounds of treatment for a rare eye cancer weekly drug infusions that could cost nearly $50,000 each Paul Davis learned Medicare had abruptly stopped paying the bills.
After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the
Your money or your life: Patient on $50,000-a-week cancer drug fears leaving behind huge medical debt dailyrepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyrepublic.com Daily Mail and Mail on Sunday newspapers.
After several rounds of treatment for a rare eye cancer — weekly drug infusions that could cost nearly $50,000 each — Paul Davis learned Medicare had abruptly stopped paying the
Medicare suddenly stopped paying for the pricey drug that prolongs his life. As he waits for an appeal, this retired physician wonders if he should give up treatment to spare his family the cost.